This Article Full Text (PDF) All Versions of this Article: 1933719107310306v1 15/2/179    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Friel, A. M. Articles by Morrison, J. J. Search for Related Content PubMed PubMed Citation Articles by Friel, A. M. Articles by Hynes, P. G. Articles by Sexton, D. J. Articles by Smith, T. J. Articles by Morrison, J. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Risk Pregnancy Hazardous Substances DB PROSTAGLANDIN F2ALPHA Social Bookmarking                         What's this?

Expression Levels of mRNA for Rho A/Rho Kinase and Its Role in Isoprostane-Induced Vasoconstriction of Human Placental and Maternal Vessels

Department of Obstetrics and Gynaecology, National University of Ireland, Galway, Clinical Science Institute, University College Hospital, Galway, Ireland, National Centre for Biomedical Engineering Science National University of Ireland, Galway

Paul G. Hynes, BSc

Department of Obstetrics and Gynaecology, National University of Ireland, Galway, Clinical Science Institute, University College Hospital, Galway, Ireland, National Centre for Biomedical Engineering Science National University of Ireland, Galway

Donal J. Sexton, MB

Department of Obstetrics and Gynaecology, National University of Ireland, Galway, Clinical Science Institute, University College Hospital, Galway, Ireland

Terry J. Smith, PhD

National Centre for Biomedical Engineering Science National University of Ireland, Galway

John J. Morrison, MD

Department of Obstetrics and Gynaecology, National University of Ireland, Galway, Clinical Science Institute, University College Hospital, Galway, Ireland, john.morrison{at}nuigalway.ie, National Centre for Biomedical Engineering Science National University of Ireland, Galway

Preeclampsia is characterized by intense and prolonged vasoconstriction. Rho A—mediated calcium sensitization is central to prolonged contractility of vascular smooth muscle. The aims of this study are (1) to investigate mRNA expression levels of Rho A/Rho kinases in placental tissues from normotensive and preeclamptic women and (2) to investigate the effects of 2 isoprostanes, 8-iso prostaglandin F₂ (8-iso PGF₂ ) and 8-iso prostaglandin E₂ (8-iso PGE₂), on small placental and myometrial vessel resistance and to determine if their effects were mediated via the Rho kinase pathway. Real-time reverse transcription polymerase chain reaction for Rho A, ROCK I, and ROCK II was performed on total RNA from normotensive and preeclamptic placentae. The effects of 8- iso PGF₂ and 8-iso PGE₂ (alone and with the specific Rho kinase inhibitor Y-27632) on placental and myometrial vessels (<400 µm) were measured and compared with control recordings. Rho A mRNA expression levels were significantly higher in placentae from preeclamptic women than in placentae from normotensive women (P < .01). There was no significant difference in expression levels of ROCK I and ROCK II between both tissue types (P > .05). Both isoprostanes exerted a significant concentration-dependent vasocontractile effect on both vessel types (P < .001). This effect was antagonized by Y-27632 in placental arteries but not in myometrial arteries. Increased Rho A mRNA expression in placentae from preeclamptic women is suggestive of a role for the Rho kinase pathway in the modulation of the placental vasculature in this condition. Isoprostanes exert their vasocontractile effect, in placental vasculature, in part via the Rho kinase pathway.

Key Words: Preeclampsia • pregnancy • placenta • Rho A.

This version was published on February 1, 2008

Reproductive Sciences, Vol. 15, No. 2, 179-188 (2008)
DOI: 10.1177/1933719107310306


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				H. Peterson, H. Laivuori, E. Kerkela, H. Jiao, L. Hiltunen, S. Heino, I. Tiala, S. Knuutila, V. Rasi, J. Kere, et al. ROCK2 allelic variants are not associated with pre-eclampsia susceptibility in the Finnish population Mol. Hum. Reprod., July 1, 2009; 15(7): 443 - 449. [Abstract] [Full Text] [PDF]